Marco DAVILA

Person

Tampa, FL, US

People

Patents Grantslast 30 patents

Information Patent Grant
Bispecific antibody for cancer immunotherapy
- Patent number 12,077,590
- Issue date Sep 3, 2024
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Marco L. Davila
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Chimeric antigen receptors with mutated CD28 costimulatory domains
- Patent number 12,065,474
- Issue date Aug 20, 2024
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Marco L. Davila
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
CAR T cells that target B-cell antigens
- Patent number 12,036,242
- Issue date Jul 16, 2024
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Marco L. Davila
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions and methods for targeting CD33-expressing cancers
- Patent number 12,037,394
- Issue date Jul 16, 2024
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Marco L. Davila
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for targeting CD99-expressing cancers
- Patent number 12,036,273
- Issue date Jul 16, 2024
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Marco L. Davila
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CD123-binding chimeric antigen receptors
- Patent number 11,976,121
- Issue date May 7, 2024
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Marco L. Davila
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods for targeting CLEC12A-expressing cancers
- Patent number 11,951,129
- Issue date Apr 9, 2024
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Marco L. Davila
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Recombinant CD123-binding antibodies
- Patent number 11,525,004
- Issue date Dec 13, 2022
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Marco L. Davila
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Artificial antigen presenting cells for genetic engineering of immu...
- Patent number 11,524,988
- Issue date Dec 13, 2022
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Marco Davila
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods for targeting CD33-expressing cancers
- Patent number 11,479,606
- Issue date Oct 25, 2022
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Marco L. Davila
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
TIM3-binding chimeric antigen receptors
- Patent number 11,458,169
- Issue date Oct 4, 2022
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Marco L. Davila
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Chimeric antigen receptors with enhanced NFκB signaling
- Patent number 11,434,290
- Issue date Sep 6, 2022
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Marco L. Davila
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
CD83 AND ALLO- AND AUTOIMMUNE CONDITIONS
- Publication number 20250052748
- Publication date Feb 13, 2025
- Regents of the University of Minnesota
- Brian Betts
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CHIMERIC ANTIGEN RECEPTORS WITH MUTATED DAP10 COSTIMULATORY DOMAINS
- Publication number 20250025503
- Publication date Jan 23, 2025
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Marco Davila
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
UNIVERSAL TIL CYTOTOXICITY ASSAY
- Publication number 20250003954
- Publication date Jan 2, 2025
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Matthew BEATTY
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS FOR TARGETING CD33-EXPRESSING CANCERS
- Publication number 20240376201
- Publication date Nov 14, 2024
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Marco L. Davila
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TARGETING CD99-EXPRESSING CANCERS
- Publication number 20240299519
- Publication date Sep 12, 2024
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Marco L. Davila
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CAR T CELLS THAT TARGET B-CELL ANTIGENS
- Publication number 20240299456
- Publication date Sep 12, 2024
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Marco L. Davila
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF USING ANTI-CD83 CHIMERIC ANTIGEN RECEPTOR EXPRESSING T C...
- Publication number 20240269284
- Publication date Aug 15, 2024
- H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC
- Marco Davila
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DUAL EGFR-MUCI CHIMERIC CANTIGEN RECEPTOR T CELLS
- Publication number 20240252636
- Publication date Aug 1, 2024
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Marco DAVILA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CUSTOMIZED CHIMERIC ANTIGEN RECEPTOR POLYPEPTIDES
- Publication number 20240226294
- Publication date Jul 11, 2024
- H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC
- Marco L. Davila
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD83 CHIMERIC ANTIGEN RECEPTOR EXPRESSING T REGULATORY CELLS
- Publication number 20240197779
- Publication date Jun 20, 2024
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Marco Davila
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS FOR TREATING CD83-EXPRESSING CANCER
- Publication number 20240173411
- Publication date May 30, 2024
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Marco L. Davila
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS TO REDUCE THERAPEUTIC T CELL TOXICITY
- Publication number 20240139322
- Publication date May 2, 2024
- H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC
- Marco L. Davila
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CUSTOMIZED CHIMERIC ANTIGEN RECEPTOR POLYPEPTIDES
- Publication number 20240131157
- Publication date Apr 25, 2024
- H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC
- Marco L. Davila
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
BI-SPECIFIC CAR T CCELLS FOR B CELL MALIGNANCIES
- Publication number 20240091356
- Publication date Mar 21, 2024
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Marco DAVILA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BI-SPECIFIC CHIMERIC ANTIGEN RECEPTOR T CELLS TARGETING CD83 AND IN...
- Publication number 20230390391
- Publication date Dec 7, 2023
- Regents of the University of Minnesota
- Brian Betts
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CHIMERIC ANTIGEN RECEPTOR T CELLS FOR TREATING AUTOIMMUNITY
- Publication number 20230321239
- Publication date Oct 12, 2023
- H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC
- Brian BETTS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CHIMERIC ANTIGEN RECEPTORS WITH ENHANCED NFKB SIGNALING
- Publication number 20230265184
- Publication date Aug 24, 2023
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Marco L. Davila
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
DUAL CHIMERIC ANTIGEN RECEPTOR T CELLS TARGETING CCD99- AND CLEC12A...
- Publication number 20230257477
- Publication date Aug 17, 2023
- H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC
- Marco L. Davila
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ARTIFICIAL ANTIGEN PRESENTING CELLS FOR GENETIC ENGINEERING OF IMMU...
- Publication number 20230250151
- Publication date Aug 10, 2023
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Marco DAVILA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Dual EGFR-MUC1 Chimeric Antigen Receptor T Cells
- Publication number 20230203168
- Publication date Jun 29, 2023
- Marco L. Davila
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TARGETING CD33-EXPRESSING CANCERS
- Publication number 20230121135
- Publication date Apr 20, 2023
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Marco L. Davila
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Systems and Methods for Producing Efficacious Regulatory T Cells
- Publication number 20230051885
- Publication date Feb 16, 2023
- H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC
- Marco L. Davila
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
AKT INHIBITORS FOR ENHANCING CHIMERIC T CELL PERSISTENCE
- Publication number 20230039099
- Publication date Feb 9, 2023
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Marco L. Davila
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTI-CD83 CHIMERIC ANTIGEN RECEPTOR EXPRESSING T REGULATORY CELLS
- Publication number 20220289862
- Publication date Sep 15, 2022
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Marco Davila
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CHIMERIC ANTIGEN RECEPTORS FOR TREATING MYELOID MALIGNANCIES
- Publication number 20220289813
- Publication date Sep 15, 2022
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Marco Davila
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
THERAPEUTIC B-CELLS ENGINEERED TO EXPRESS BISPECIFIC T CELL ENGAGER...
- Publication number 20220241332
- Publication date Aug 4, 2022
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Marco L. Davila
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CHIMERIC ANTIGEN RECEPTORS WITH MUTATED CD28 COSTIMULATORY DOMAINS
- Publication number 20220235114
- Publication date Jul 28, 2022
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Marco DAVILA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC T-CELLS WITH MODIFIED EXPRESSION OF T-BET, EOMES, AND c...
- Publication number 20220228114
- Publication date Jul 21, 2022
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Marco L. Davila
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ARTIFICIAL ANTIGEN PRESENTING CELLS COMPRISING LIGANDS FOR NKG2D FO...
- Publication number 20220154144
- Publication date May 19, 2022
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Marco DAVILA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RAPID PRODUCTION, EXPANSION, AND INCREASED PURITY OF CAR-T CELLS US...
- Publication number 20210236547
- Publication date Aug 5, 2021
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Marco DAVILA
- C07 - ORGANIC CHEMISTRY

Marco DAVILA

Person

Patents Grantslast 30 patents

Bispecific antibody for cancer immunotherapy

Chimeric antigen receptors with mutated CD28 costimulatory domains

CAR T cells that target B-cell antigens

Compositions and methods for targeting CD33-expressing cancers

Compositions and methods for targeting CD99-expressing cancers

CD123-binding chimeric antigen receptors

Compositions and methods for targeting CLEC12A-expressing cancers

Recombinant CD123-binding antibodies

Artificial antigen presenting cells for genetic engineering of immu...

Compositions and methods for targeting CD33-expressing cancers

TIM3-binding chimeric antigen receptors

Chimeric antigen receptors with enhanced NFκB signaling

Patents Applicationslast 30 patents

CD83 AND ALLO- AND AUTOIMMUNE CONDITIONS

CHIMERIC ANTIGEN RECEPTORS WITH MUTATED DAP10 COSTIMULATORY DOMAINS

UNIVERSAL TIL CYTOTOXICITY ASSAY

COMPOSITIONS AND METHODS FOR TARGETING CD33-EXPRESSING CANCERS

COMPOSITIONS AND METHODS FOR TARGETING CD99-EXPRESSING CANCERS

CAR T CELLS THAT TARGET B-CELL ANTIGENS

METHODS OF USING ANTI-CD83 CHIMERIC ANTIGEN RECEPTOR EXPRESSING T C...

DUAL EGFR-MUCI CHIMERIC CANTIGEN RECEPTOR T CELLS

CUSTOMIZED CHIMERIC ANTIGEN RECEPTOR POLYPEPTIDES

ANTI-CD83 CHIMERIC ANTIGEN RECEPTOR EXPRESSING T REGULATORY CELLS

METHODS FOR TREATING CD83-EXPRESSING CANCER

COMPOSITIONS AND METHODS TO REDUCE THERAPEUTIC T CELL TOXICITY

CUSTOMIZED CHIMERIC ANTIGEN RECEPTOR POLYPEPTIDES

BI-SPECIFIC CAR T CCELLS FOR B CELL MALIGNANCIES

BI-SPECIFIC CHIMERIC ANTIGEN RECEPTOR T CELLS TARGETING CD83 AND IN...

CHIMERIC ANTIGEN RECEPTOR T CELLS FOR TREATING AUTOIMMUNITY

CHIMERIC ANTIGEN RECEPTORS WITH ENHANCED NFKB SIGNALING

DUAL CHIMERIC ANTIGEN RECEPTOR T CELLS TARGETING CCD99- AND CLEC12A...

ARTIFICIAL ANTIGEN PRESENTING CELLS FOR GENETIC ENGINEERING OF IMMU...

Dual EGFR-MUC1 Chimeric Antigen Receptor T Cells

COMPOSITIONS AND METHODS FOR TARGETING CD33-EXPRESSING CANCERS

Systems and Methods for Producing Efficacious Regulatory T Cells

AKT INHIBITORS FOR ENHANCING CHIMERIC T CELL PERSISTENCE

ANTI-CD83 CHIMERIC ANTIGEN RECEPTOR EXPRESSING T REGULATORY CELLS

CHIMERIC ANTIGEN RECEPTORS FOR TREATING MYELOID MALIGNANCIES

THERAPEUTIC B-CELLS ENGINEERED TO EXPRESS BISPECIFIC T CELL ENGAGER...

CHIMERIC ANTIGEN RECEPTORS WITH MUTATED CD28 COSTIMULATORY DOMAINS

THERAPEUTIC T-CELLS WITH MODIFIED EXPRESSION OF T-BET, EOMES, AND c...

ARTIFICIAL ANTIGEN PRESENTING CELLS COMPRISING LIGANDS FOR NKG2D FO...

RAPID PRODUCTION, EXPANSION, AND INCREASED PURITY OF CAR-T CELLS US...